Find Federal Grants
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
National Institutes of Health · PAR-27-013
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
National Institutes of Health · PAR-27-012
National Institutes of Health · PAR-27-011
Clinical Trials and Ancillary Studies Conducted within NIH-Funded Clinical Trial Research Networks (UG3/UH3 - Clinical Trial Required)
National Institutes of Health · PAR-27-007
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers
National Institutes of Health · PAR-27-008
HEAL Initiative: Optimization of Therapeutic Medical Devices through Team Science Mechanistic Research (RM1)
National Institutes of Health · RFA-NS-26-028
Impact of Immunotherapies on CNS Outcomes in People with HIV: Potential Benefits, Challenges and Risks
National Institutes of Health · RFA-MH-27-110
National Institutes of Health · PAR-26-093
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Center for Medicare and Medicaid Services · CMS-2W2-27-001
U.S. Mission to North Macedonia · SMK800-26-PAS001
Centers for Disease Control - NCIPC · CDC-RFA-CE21-210206CONT26
Centers for Disease Control - NCIPC · CDC-RFA-CE-26-0061
Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
National Institutes of Health · RFA-NS-26-032
National Institutes of Health · RFA-NS-26-031
National Institutes of Health · RFA-NS-26-034
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
National Institutes of Health · RFA-MH-27-120
National Institutes of Health · RFA-MH-28-100
Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
National Institutes of Health · PAR-26-129
Office of National Drug Control Policy · NCI-NCI-26-001
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
National Institutes of Health · PAR-26-149